Rohinton S Tarapore
4PUBLICATIONS
95CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Feb 24, 2024
Safety and pharmacokinetics of ONC201 (dordaviprone) administered two consecutive days per week in pediatric patients with H3 K27M-mutant glioma.Yazmin Odia, Carl Koschmann, Nicholas A Vitanza
|Feb 09, 2024
ONC201 (Dordaviprone) in Recurrent H3 K27M-Mutant Diffuse Midline Glioma.Isabel Arrillaga-Romany, Sharon L Gardner, Yazmin Odia
|Aug 16, 2023
Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways.Sriram Venneti, Abed Rahman Kawakibi, Sunjong Ji
|Nov 16, 2022
Phase I dose escalation and expansion trial of single agent ONC201 in pediatric diffuse midline gliomas following radiotherapy.Sharon L Gardner, Rohinton S Tarapore, Jeffrey Allen
Pageof 1
Frequent Collaborators
3 joint publications
Carl Koschmann
2 joint publications
Minesh Mehta
2 joint publications
Nicole Shonka
2 joint publications
Nicholas Butowski
2 joint publications
John de Groot
2 joint publications
Tracy T Batchelor
2 joint publications
Rebecca A Harrison
2 joint publications
Ashley Sumrall
2 joint publications
Isabel Arrillaga-Romany
2 joint publications
Patrick Y Wen
